
Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%–ketorolac 0.3% administered during cataract surgery
Author(s) -
Eric D. Donnenfeld,
Daniel Mychajlyszn,
Andrey Mychajlyszyn,
Rebecca L. Stein
Publication year - 2021
Publication title -
journal of cataract and refractive surgery/journal of cataract and refractive surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 142
eISSN - 1873-4502
pISSN - 0886-3350
DOI - 10.1097/j.jcrs.0000000000000855
Subject(s) - medicine , ketorolac , fentanyl , anesthesia , cataract surgery , phacoemulsification , epinephrine , ambulatory , randomized controlled trial , opioid , surgery , analgesic , visual acuity , receptor
To compare pain and the need for the opioid fentanyl use associated with the administration of phenylephrine 1.0%-ketorolac 0.3% (P/K) with those of epinephrine administration during cataract surgery.